Redenlab is proud to announce our participation in the 14th International Conference on Frontotemporal Dementias (ICFTD), to be held in Amsterdam, The Netherlands, from September 19 – 22, 2024.

Dr. Adam Vogel and his colleagues will be presenting cutting-edge research that highlights the transformative potential of speech and language analytics in diagnosing and understanding neurodegenerative diseases. Our team’s contributions include one oral presentation and three poster presentations that focus on innovative approaches to detecting and monitoring Frontotemporal Dementia, Alzheimer’s Disease, and Schizophrenia.

Presentations include:

• Oral presentation:
  Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech
  
• Poster presentations:
  • Overt and Subtle Temporal Motor Impairments in PPA and bvFTD
    (In collaboration with UCSF and U Texas at Austin)
  • The Utility of Speech and Language Analytics for Screening Alzheimer’s Disease and Schizophrenia.
  • Update on the Current State of Speech and Language Testing in Alzheimer’s Disease

We are honored to share these significant developments with the global research community and look forward to meaningful discussions at ICFTD 2024.

For more information about the conference, please visit the ICFTD 2024 website.